Akèy › Maladi Alzheimer › New York
Etid klinik pou Maladi Alzheimer nan New York
37 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan New York.
Vil nan New York
- New York City21 etid
- Queens8 etid
- Newburgh5 etid
- Albany4 etid
- Staten Island4 etid
- Syracuse4 etid
- Rochester3 etid
- Buffalo3 etid
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, New York
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT06887192A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1656, New Windsor
- Local Institution - 2619, Staten Island
- Local Institution - 1658, Woodmere
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 28, 2026 · NCT06937229A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Alzheimer's Disease Research Center, Albany
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Mid Hudson Medical Research PLLC, New Windsor
- SUNY Upstate Medical University, Syracuse
- Five Towns Neurology, PC, Woodmere
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Alzheimer's Disease Research Center, Albany
- Adams Clinic Harlem, New York
Ap rekriteFaz 2
Laj 55 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT06847321Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Basil Clinical, Laurelton
- Weill Cornell Medical College, New York
- Adams Clinical Harlem, New York
- ak 2 plis
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Neurological Associates Albany, Albany
- Dent Neurosciences Research Center, Inc, Amherst
- University at Buffalo - UBMD Neurology, Buffalo
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Local Institution - 2647, Brooklyn
- Richmond Behavioral Associates, Staten Island
- Walnut Clinical Research, Valley Stream
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1610, Inwood
- Mid Hudson Medical Research, New Windsor
- Five Towns Neurology PC -Woodmere - 923 Broadway, Woodmere
Ap rekriteFaz 3
Laj 55 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT07011732A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Basil Clinical, Laurelton
Ap rekriteFaz 3
Laj 55 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07717411Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- University at Buffalo - UBMD Neurology, Buffalo
- The Feinstein Institute for Medical Research, Manhasset
- Mid Hudson Medical Research, New Windsor
- ak 1 plis
Ap rekriteFaz 2
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alzheimer Disease Research Center (ADRC) ( Site 1000), Albany
- Mid Hudson Medical Research ( Site 1050), New Windsor
- Basil Clinical ( Site 1065), Queens
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
- The Research Foundation for State University of New York, Buffalo
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07178210A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- NYU Langone Health, New York
- SUNY Upstate Medical University, Syracuse
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Early Age-Related Hearing Loss Investigation (EARHLI)
- Columbia University Medical Center, New York
Ap rekrite
Laj 55 a 75 · Tout sèks · Mizajou Aug 12, 2026 · NCT06174038The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
- New York University, New York
- Mount Sinai, New York
Ap rekrite
Laj 55 a 85 · Tout sèks · Mizajou Aug 6, 2026 · NCT05988385Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 a 90 · Tout sèks · Mizajou Aug 4, 2026 · NCT04239079Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- New York University Medical Center, New York
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- New York University Medical Center, New York
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
- NYU Rory Meyers College of Nursing and VNS Health, New York
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT07182357Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
- Columbia University Irving Medical Center, New York
Ap rekriteFaz 2Volontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04576793Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
- Weill Cornell Medicine Brain Health Imaging Institute, New York
Ap rekriteFaz 2
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07553338[18F]PI-2620 Phase 3 Histopathological Study
- Velocity Clinical Research, East Syracuse
- Ichor Research, Syracuse
Ap rekriteFaz 3
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688Trial-Ready Cohort-Down Syndrome (TRC-DS)
- New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS Only, Staten Island
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Late Onset Alzheimer's Disease
- Columbia University Irving Medical Center, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05010603Tele-Savvy for Latino Caregivers
- University of Rochester School of Nursing, Rochester
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT07290387Aβ Dynamics in LLMD
- NYU Langone Health, New York
- Nathan S. Kline Institute for Psychiatric Research, Orangeburg
Ap rekriteFaz 4
Laj 60 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT05004987Genetic Studies of Early-onset Dementia
- Columbia University Irving Medical Center, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 35 ak plis · Tout sèks · Mizajou Apr 29, 2026 · NCT04906863Tau Networks in Psychotic Alzheimer's Disease
- The Feinstein Institutes for Medical Research, Manhasset
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 65 a 85 · Tout sèks · Mizajou Apr 8, 2026 · NCT05847192Dementia Caregivers' Link to Assistance and Resources
- VNS Health Home Care, New York
Ap rekriteVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Mar 13, 2026 · NCT06860035Evaluating the Efficacy of the Pain Identification and Communication Toolkit
- Weill Cornell Medicine, New York
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT06168604Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Staten Island
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Feb 2, 2026 · NCT07105709Daridorexant to Prevent Post-cardiotomy Delirium
- University of Rochester Medical Center, Rochester
Ap rekriteFaz 2
Laj 60 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT07217912Innate Immunity Stimulation Via TLR9 in Early AD
- NYU Langone Health, New York
Ap rekriteFaz 1
Laj 60 a 85 · Tout sèks · Mizajou Jan 7, 2026 · NCT05606341NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Ap rekriteEtid obsèvasyon
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106Triage Survey for Neurology Research Eligibility
- Berman Clinical, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 27, 2023 · NCT06104852Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.